|
Index of reports
> Cases with Myocardial Infarction ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) where reactions include myocardial infarction. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Reyataz side effects in 57 year old female
Reported by a physician from United States on 2012-08-10
Patient: 57 year old female
Reactions: Chronic Obstructive Pulmonary Disease, Myocardial Infarction, Arrhythmia
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in male
Reported by a physician from Russian Federation on 2012-07-03
Patient: male, weighing 85.0 kg (187.0 pounds)
Reactions: Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Dosage: 1tab per day
Administration route: Oral
Indication: HIV Infection
Start date: 2011-05-12
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-12
Possible Reyataz side effects in 45 year old male
Reported by a consumer/non-health professional from Australia on 2011-11-23
Patient: 45 year old male
Reactions: Nausea, Myocardial Infarction
Drug(s) suspected as cause:
Reyataz
Dosage: 1df:300mg/100mg
Indication: Antiretroviral Therapy
Start date: 2006-01-01
Truvada
Indication: Antiretroviral Therapy
Start date: 2006-01-01
Metoprolol Tartrate
Acetylsalicylic Acid SRT
Ritonavir
Indication: Antiretroviral Therapy
Start date: 2006-01-01
Rosuvastatin
Clopidogrel Bisulfate
Ramipril
|
